Acute myeloid leukemia (AML) is the most common malignant myeloid disorder of progenitor cells in myeloid hematopoiesis and exemplifies a genetically heterogeneous disease. The patients with AML also
An innovative multikinase inhibitor (H89)-based antitumor immunotherapy in colorectal cancer (CRC) is presented. The study was designed to evaluate the effect of H89 on colon tumor growth and carcinog
Global FMS-like Tyrosine Kinase 3 Inhibitors Market Report 2023 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and
